Role of Intracellular Glutathione in Cell Sensitivity to the Apoptosis Induced by Tumor Necrosis Factor α–Related Apoptosis-Inducing Ligand/Anticancer Drug Combinations
- 15 April 2005
- journal article
- Published by American Association for Cancer Research (AACR) in Clinical Cancer Research
- Vol. 11 (8) , 3075-3083
Abstract
Purpose: We have recently shown that combination of tumor necrosis factor α–related apoptosis-inducing ligand (TRAIL) with anticancer drugs induced an apoptotic cell death pathway involving both caspases and mitochondria. The present work further explores the role of intracellular reduced glutathione (GSH) level in cell sensitivity to this cell death pathway.Keywords
This publication has 43 references indexed in Scilit:
- Mitogen-activated protein kinases in apoptosis regulationOncogene, 2004
- Human normal hepatocytes are susceptible to apoptosis signal mediated by both TRAIL-R1 and TRAIL-R2Cell Death & Differentiation, 2003
- Strategies for reversing drug resistanceOncogene, 2003
- MitochondriaCell, 2003
- CCNU-dependent potentiation of TRAIL/Apo2L-induced apoptosis in human glioma cells is p53-independent but may involve enhanced cytochrome c releaseOncogene, 2001
- Safety and antitumor activity of recombinant soluble Apo2 ligandJournal of Clinical Investigation, 1999
- Expression of Bcl-2 Increases Intracellular Glutathione by Inhibiting Methionine-Dependent GSH EffluxBiochemical and Biophysical Research Communications, 1998
- Potential for selective modulation of glutathione in cancer chemotherapyChemico-Biological Interactions, 1998
- Oxidative stress as a mediator of apoptosisImmunology Today, 1994
- Glutathione-conferred resistance to antineoplastics: Approaches toward its reductionCancer Treatment Reviews, 1984